Tradename | Company | Number | Date | Products |
---|---|---|---|---|
RELISTOR | Salix Pharmaceuticals | N-208271 RX | 2016-07-19 | 1 products, RLD, RS |
RELISTOR | Salix Pharmaceuticals | N-021964 RX | 2008-04-24 | 3 products, RLD, RS |
Brand Name | Status | Last Update |
---|---|---|
relistor | New Drug Application | 2024-05-14 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
constipation | — | D003248 | K59.0 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Methylnaltrexone Bromide, Relistor, Salix | |||
8524276 | 2031-03-10 | DP | |
8956651 | 2031-03-10 | DP | |
9314461 | 2031-03-10 | DP | |
10307417 | 2031-03-10 | DP | |
10376505 | 2031-03-10 | DP | |
8420663 | 2029-09-30 | U-1185 | |
9180125 | 2029-09-30 | DP | U-1185 |
9492445 | 2029-09-30 | DP | U-1185 |
9724343 | 2029-09-30 | DP | U-1185 |
Methylnaltrexone Bromide, Relistor, Salix Pharms | |||
8247425 | 2030-12-31 | U-1185 | |
8822490 | 2029-09-30 | DP | U-1185 |
8552025 | 2024-04-08 | DP | |
9669096 | 2024-04-08 | DP | |
10376584 | 2024-04-08 | DP | U-1185 |
Code | Description |
---|---|
J2212 | Injection, methylnaltrexone, 0.1 mg |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Constipation | D003248 | — | K59.0 | — | 2 | 6 | 3 | 1 | 12 |
Opioid-induced constipation | D000079689 | — | — | — | 2 | 5 | 3 | 1 | 11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Ileus | D045823 | — | K56.7 | — | 1 | 2 | — | — | 3 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | 1 | 2 | — | — | 2 |
Intestinal diseases | D007410 | — | K63.9 | — | 1 | 1 | — | — | 2 |
Ventral hernia | D006555 | EFO_1001866 | K43 | — | — | 1 | — | — | 1 |
Hernia | D006547 | — | K40-K46 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 4 | 1 | — | — | — | 5 |
Gastrointestinal diseases | D005767 | — | — | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Liver diseases | D008107 | EFO_0001421 | K70-K77 | 1 | — | — | — | — | 1 |
Renal insufficiency | D051437 | — | N19 | 1 | — | — | — | — | 1 |
Drug common name | Methylnaltrexone |
INN | methylnaltrexone bromide |
Description | Methylnaltrexone is a member of phenanthrenes. |
Classification | Small molecule |
Drug class | narcotic agonists/antagonists (normorphine type) |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[N+]1(CC2CC2)CC[C@]23c4c5ccc(O)c4O[C@H]2C(=O)CC[C@@]3(O)[C@H]1C5 |
PDB | — |
CAS-ID | 83387-25-1 |
RxCUI | — |
ChEMBL ID | CHEMBL1186579 |
ChEBI ID | — |
PubChem CID | 5361918 |
DrugBank | DB06800 |
UNII ID | RFO6IL3D3M (ChemIDplus, GSRS) |